Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

RDO nets $9.3mm for Neuralstem

Executive Summary

CNS-focused Neuralstem Inc. netted $9.3mm through the registered direct offering of 3.57mm units priced at $2.80 each (a 14% discount) to institutional investors. Each unit consists of one common share and 3/4 of a common stock purchase warrant. The three-year warrants are exercisable at $3.25. Noble Financial Capital Markets was the placement agent.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Private Investment in Public Equity

Related Companies